Participated · Equity · Oct 2023

Tilak Healthcare's core product is OdySight, a CE‑marked Class I medical device that combines a mobile video game with remote monitoring to track visual acuity for retinal diseases such as AMD and diabetic retinopathy. OdySight is financed by the French social security system under the government’s ‘Article 51’ scheme for experimental technologies and is already used in Europe and the United States. Since launch it has improved care for about 12,000 patients and is distributed in part via a co-promotion partnership with Laboratoires Théa. The company says its telemedicine model has created a sustainable business model and is on the path to achieve profitability by 2025. Tilak reported a 500% increase in recurring revenue between 2022 and 2023. The company was founded in 2016 within the iBionext ecosystem and has raised €22 million in total funding to date. Tilak Healthcare develops OdySight, a CE‑labelled Class I medical game for mobile devices that remotely monitors visual acuity in patients with retinal diseases such as age‑related macular degeneration and diabetic retinopathy. The app has been used to optimize care pathways for thousands of patients across Europe and the USA and is used by nearly 20% of retinologists in France. The company combines video‑game developers and medical scientists under guidance from Professor José‑Alain Sahel and is led by CEO Edouard Gasser. Products are clinically validated, compliant with medical device regulations, and built to protect patient privacy. Tilak is expanding internationally (USA, Spain, Belgium) and plans to launch OdySight Care for clinical trials and health‑insurance preventative monitoring. Financially, the company has completed a new fundraising round and has raised over €12 million since its 2016 founding. Tilak Healthcare develops medically-prescribed video games for the diagnosis and follow-up of chronic diseases. Cofounded with iBionext in May 2016 and led by CEO Edouard Gasser, the company is specialized in digital healthcare. It is dedicated to creating disruptive videogames that can be prescribed to monitor and follow up patients. The company's first application targets ophthalmology, with a focus on macular diseases that affect many patients in aging populations of developed countries. Tilak intends to use new funding to accelerate the development of its therapeutic mobile games. The company raised €2.5m from iBionext Growth Fund.

Participated · Equity · Jun 2018

Lendix operates an online lending marketplace that matches individual and institutional lenders with companies applying for loans, combining algorithmic credit scoring with human underwriting. The company has built an intelligence tool called Iris to aggregate and parse European open-company data for credit insights and potential fraud detection. Lendix currently serves borrowers and lenders in France, Spain and Italy and has opened local offices in Madrid and Milan. The platform already hosts a mix of users and institutional investors, which the company says makes it easier to launch new markets. Lendix aims to speed up lending decisions (currently delivering rates within 48 hours, targeting half a day) and to differentiate from traditional banks. The company plans rapid geographic expansion across Continental Europe over the coming year. Lendix operates a loan marketplace focused on financing European small and medium-sized enterprises. The platform offers loans ranging from €30,000 to €5 million. Led by founder Olivier Goy and COO Patrick de Nonneville, Lendix uses institutional vehicles to fund originated loans. A prior €90m vehicle closed in July 2017 and lent to nearly 250 European SMEs. The new financing vehicle increases Lendix’s capacity to support the growth of more than 600 SMEs. As part of its rollout, €120m of the new vehicle is already committed and the first loans from it will be made in February. Lendix operates a marketplace that matches individual lenders with small and medium companies, typically managing medium-term loans of 3 to 6 years with annual returns of 4–9% for lenders. In its first year the platform managed $22.5 million (€20 million) in business loans and the average amount lent per loan is about €220. Lendix recently acquired competitor Finsquare, giving it the ability to manage short-term loans in addition to its existing medium-term offerings. The company says some investors have committed additional capital to deploy on the platform, and it plans to use funding to finance more deals. Lendix intends to expand into other European countries, starting with Spain and Italy, and will pursue the required licenses for each market. The startup is positioning itself as a simpler, faster alternative to traditional banks for SMEs and is exploring product ideas such as automated reinvestment, tiered loan portfolios, and a secondary matching market for selling positions.

Participated · Series A · Jan 2018

Saagie provides a smart big-data processing platform as both a SaaS and on-premise solution that leverages AI to speed development of business applications. The platform offers pre-integrated open source blocks for collecting, analyzing and processing large enterprise data. It is massively used in the bank and insurance industry. The company was founded in 2013 by CEO Arnaud Muller and is based in Petit-Quevilly, France, with offices in Paris and San Francisco. Saagie intends to use recent funding to continue improving the product and to expand its business internationally, including plans to open in NYC. The company recently completed a €5M Series A+ financing to support those efforts. Saagie provides a big-data platform designed to help businesses tap into and operationalize large-scale data and analytics. The company serves enterprise clients including Vente‑privee.com, Johnson & Johnson, Ferrero, Caisse d’Épargne Normandie, BudgetBox and Bouygues Énergies & Services. For Vente‑privee.com Saagie has optimized the product recommendation engine; with Bouygues it is working to improve availability and maintenance of industrial equipment. Saagie was launched in 2013 and previously raised €850,000 in summer 2015 from earlier backers. The startup recently hired Jerome Trédan, formerly of Microsoft, as Vice President of Marketing and Sales to restructure sales and marketing. The new funding is earmarked to accelerate international growth and to further develop the company’s artificial intelligence technology and product.